QUANTRO THERAPEUTICS
QUANTRO Therapeutics is a research-based organization dedicated to discovering and developing novel therapeutics that interfere with disease-causing transcriptional programs in cancer and other diseases. QUANTRO Therapeutics is located in Vienna, Austria.
QUANTRO THERAPEUTICS
Industry:
Biotechnology Pharmaceutical
Founded:
2019-01-01
Address:
Vienna, Wien, Austria
Country:
Austria
Website Url:
http://www.quantro-tx.com
Total Employee:
1+
Status:
Active
Contact:
+43 122 66001-20
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
4P Therapeutics
4P Therapeutics is a private company focused on the research and development of novel drug delivery technologies and therapeutics.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Talisman Therapeutics
Talisman Tx is a stem cell research and development company committed to revolutionising the discovery of treatments for Alzheimer's disease
Current Advisors List
Official Site Inspections
http://www.quantro-tx.com
- Host name: s3474.fra1.stableserver.net
- IP address: 192.250.229.115
- Location: Las Vegas United States
- Latitude: 36.1682
- Longitude: -115.2166
- Metro Code: 839
- Timezone: America/Los_Angeles
- Postal: 89107
More informations about "QUANTRO Therapeutics"
QUANTRO Therapeutics - Crunchbase Company Profile โฆ
Contact Email [email protected]; Phone Number +43 122 66001-20; QUANTRO Therapeutics is a research-based organization dedicated to โฆSee details»
QUANTRO Therapeutics - Vienna BioCenter
QUANTRO Therapeutics is a visionary and dynamic start-up company that strives to discover and develop novel effective therapeutics that interfere with disease-causing transcriptional โฆSee details»
Quantro Therapeutics GmbH - Life-Sciences-Europe.com
Jul 21, 2020 BIO (US) (Biotechnology Innovation Organization, formerly Biotechnology Industry Organization) ... //www.quantro-tx.com. QUANTRO Therapeutics is a transcriptomic Drug โฆSee details»
QUANTRO Therapeutics Company Profile 2024: Valuation, Funding ...
QUANTRO Therapeutics General Information Description. Developer of novel therapeutics intended to generate an unprecedented cancer drug discovery pipeline. The company's โฆSee details»
News - Vienna BioCenter
For more information: www.quantro-tx.com. About the Vienna BioCenter The Vienna BioCenter is a leading life sciences hub in Europe, offering an extraordinary combination of research, business and education in a single โฆSee details»
Company | Quantro
Jun 9, 2022 Spin-off of IMBA and IMP. QUANTRO Therapeutics GmbH was founded in Vienna, Austria, as a spin-off of the Research Institute of Molecular Pathology and the Institute of Molecular Biotechnology of the Austrian โฆSee details»
QUANTRO Therapeutics - VentureRadar
Dansk Biotek Unknown n/a DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and โฆSee details»
Cancer research: Viennese start-up breaks new ground in drug โฆ
Jun 30, 2020 The new start-up QUANTRO Therapeutics at the Vienna BioCenter uses innovative transcriptome profiling technologies in a novel drug discovery pipeline to identify โฆSee details»
QUANTRO Therapeutics - Company Profile - Tracxn
Nov 20, 2024 QUANTRO Therapeutics ranks 247th among 558 active competitors. 208 of its competitors are funded while 128 have exited. Overall, QUANTRO Therapeutics and its โฆSee details»
QUANTRO Therapeutics appoints Industry Expert Dr. Michael โฆ
Vienna, 04.04.2023: QUANTRO Therapeutics appoints Industry Expert Dr. Michael Bauer as Chief Executive Officer - QUANTRO Therapeutics, an innovative drug discovery company โฆSee details»
management CV | Quantro
Prior to joining QUANTRO, Dr. Bauer was Co-founder, CEO, and a member of the Board of Directors at Cellestia Biotech AG (Basel, Switzerland), where he led the company from an โฆSee details»
QUANTRO Therapeutics reaches a milestone in the collaboration โฆ
Jun 4, 2024 Mail: [email protected] Phone: +43 122 66001-20 www.quantro-tx.com. Media Contact MC Services AG Katja Arnold, Dr. Johanna Kobler, Shaun Brown Phone: +49 89 โฆSee details»
QUANTRO Therapeutics Launched with Breakthrough Oncology โฆ
Jul 21, 2020 Mail: [email protected] www.quantro-tx.com Media Contact MC Services AG Katja Arnold, Andreas Jungfer, Shaun Brown Phone: +49 89 210228 0 Mail: โฆSee details»
QUANTRO Therapeutics reaches a milestone in the collaboration โฆ
VIENNA, Austria, June 04, 2024 (GLOBE NEWSWIRE) -- QUANTRO Therapeutics (QUANTRO), a pioneer in the discovery of first-in-class transcription factor targeting cancer treatments, โฆSee details»
Advisory board CV | Quantro
In the following years, Sebastian held various positions within BIโs R&D organization thereby further broadening his expertise in pharmacology and translational research. From 2015 to โฆSee details»
QUANTRO Therapeutics Launched with Breakthrough Oncology โฆ
Jul 21, 2020 www.quantro-tx.com Media Contact MC Services AG Katja Arnold, Andreas Jungfer, Shaun Brown Phone: +49 89 210228 0 Mail: [email protected] About โฆSee details»
founders CV | Quantro
Company (referred to as either "the Company", "We", "Us" or "Our" in this Agreement) refers to QUANTRO Therapeutics GmbH, Dr. Bohr-Gasse 7 1030 Vienna. Cookies are small files that โฆSee details»
Privacy Policy | Quantro
QUANTRO Therapeutics GmbH FN 512795 k Dr. Bohr-Gasse 7 1030 Vienna office (at) quantro-tx.com. Definitions. Definitions of the terms used (e.g. โpersonal dataโ or โprocessingโ) can be โฆSee details»